With the addition of the new findings in this study, that the C677T variant in the folate metabolism gene MTHFR is a potential modifying factor in disulfiram pharmacotherapy for cocaine dependence, we propose that the genetic profile of an individual including findings such as these may be used to help in tailoring a more effective pharmacotherapy for CD. This evidence concerns the gene MTHFR and Cowden disease.